Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 125 Breast Neoplasms 82 Neoplasms 78 Colorectal Neoplasms 67 Neoplasm Metastasis 65 Prostatic Neoplasms 61 Leukemia, Myeloid, Acute 61 Ovarian Neoplasms 57 Recurrence 55 Pancreatic Neoplasms 55 Multiple Myeloma 52 Melanoma 40 Triple Negative Breast Neoplasms 36 Lung Neoplasms 36 Glioblastoma 36 Squamous Cell Carcinoma of Head and Neck 34 Endometrial Neoplasms 33 Lymphoma, Non-Hodgkin 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Lymphoma, Large B-Cell, Diffuse 28 Carcinoma, Renal Cell 28 Lymphoma 27 Stomach Neoplasms 26 Small Cell Lung Carcinoma 26 Carcinoma, Hepatocellular 26 Myelodysplastic Syndromes 25 Lymphoma, B-Cell 25 Advanced Solid Tumor 25 Leukemia, Lymphocytic, Chronic, B-Cell 24 Brain Neoplasms 24

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Anal Cancer Metastatic × 90 days × Clear all

NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡